125 related articles for article (PubMed ID: 25218126)
1. Statistical flaws in the development of a prediction model.
Collins GS
Am J Obstet Gynecol; 2015 Jan; 212(1):116. PubMed ID: 25218126
[No Abstract] [Full Text] [Related]
2. Reply: To PMID 24949545.
Bendifallah S; Darai E
Am J Obstet Gynecol; 2015 Jan; 212(1):116-7. PubMed ID: 25218128
[No Abstract] [Full Text] [Related]
3. Nomogram to predict recurrence in patients with early- and advanced-stage mucinous and serous borderline ovarian tumors.
Bendifallah S; Ballester M; Uzan C; Fauvet R; Morice P; Darai E
Am J Obstet Gynecol; 2014 Dec; 211(6):637.e1-6. PubMed ID: 24949545
[TBL] [Abstract][Full Text] [Related]
4. Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities?
Kajiyama H; Mizuno M; Shibata K; Umezu T; Suzuki S; Yamamoto E; Mitsui H; Sekiya R; Niimi K; Kawai M; Nagasaka T; Kikkawa F
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():305-10. PubMed ID: 25203309
[TBL] [Abstract][Full Text] [Related]
5. Minimal invasive approaches for large ovarian cysts: a careful choice.
Bellati F; Gasparri ML; Ruscito I; Caccetta J; Benedetti Panici P
Arch Gynecol Obstet; 2013 Mar; 287(3):615-6. PubMed ID: 22987258
[No Abstract] [Full Text] [Related]
6. [Precursors of ovarian carcinoma and epithelial borderline tumors: current topics in pathology].
Kiyokawa T
Nihon Rinsho; 2012 Jun; 70 Suppl 4():517-22. PubMed ID: 23156301
[No Abstract] [Full Text] [Related]
7. Trismus and diffuse polymyalgia: an unusual presentation of recurrent metastatic ovarian cancer.
Benjamin R; Zhai J; Morgan R; Prakash N
BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24835804
[TBL] [Abstract][Full Text] [Related]
8. Early stage mucinous ovarian cancer: A review.
Crane EK; Brown J
Gynecol Oncol; 2018 Jun; 149(3):598-604. PubMed ID: 29429591
[TBL] [Abstract][Full Text] [Related]
9. Assessing the risk of clinical and pathologic factors for relapse of borderline ovarian tumours.
Chang C; Chen J; Chen WA; Ho SP; Liou WS; Chiang AJ
J Obstet Gynaecol; 2017 Feb; 37(2):233-237. PubMed ID: 27922289
[TBL] [Abstract][Full Text] [Related]
10. Osteosarcoma as Malignant Mural Nodule in Ovarian Mucinous Neoplasms of Intestinal Type: Report of 2 Cases.
McFarland M; Dina R; Fisher C; McCluggage WG
Int J Gynecol Pathol; 2015 Jul; 34(4):369-73. PubMed ID: 25760909
[TBL] [Abstract][Full Text] [Related]
11. Total pelvic exenteration for pelvic recurrence after advanced epithelial ovarian cancer--A case report and literature review.
Bacalbașa N; Bălescu I
J Med Life; 2015; 8(3):263-5. PubMed ID: 26351524
[TBL] [Abstract][Full Text] [Related]
12. [Recent advances on ovarian epithelial cancer: definition, subtypes and pathologic features].
Guo DH; Zheng WX
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):624-8. PubMed ID: 24314254
[No Abstract] [Full Text] [Related]
13. Borderline ovarian mucinous neoplasm recurring as small cell carcinoma of hypercalcemic type: evidence for an epithelial histogenesis and relationship with ovarian mucinous tumors for this enigmatic neoplasm.
Mansor S; Nagarajan S; Sumathi VP; McCluggage WG
Int J Gynecol Pathol; 2011 Jul; 30(4):380-5. PubMed ID: 21623206
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Clinicopathologic and Updated Immunohistochemical Characterization of Primary Ovarian Mucinous Carcinoma.
Bassiouny D; Ismiil N; Dubé V; Han G; Cesari M; Lu FI; Slodkowska E; Parra-Herran C; Chiu HF; Naeim M; Li N; Khalifa M; Nofech-Mozes S
Int J Surg Pathol; 2018 Jun; 26(4):306-317. PubMed ID: 29338553
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
[TBL] [Abstract][Full Text] [Related]
16. Mediastinal recurrence from ovarian cystadenocarcinoma presenting as pleuro-pericardial cyst.
Lococo F; Charpentier MC; Guinet C; Brandolini J; Alifano M; Regnard JF
Eur Rev Med Pharmacol Sci; 2014; 18(15):2094-6. PubMed ID: 25070811
[TBL] [Abstract][Full Text] [Related]
17. The role and prognostic value of inducible nitric oxide synthase (iNOS) and interleukin-33 (IL-33) in serous and mucinous epithelial ovarian tumours.
Saied EM; El-Etreby NM
Ann Diagn Pathol; 2017 Apr; 27():62-68. PubMed ID: 28325363
[TBL] [Abstract][Full Text] [Related]
18. Prior appendectomy does not protect against subsequent development of malignant or borderline mucinous ovarian neoplasms.
Elias KM; Labidi-Galy SI; Vitonis AF; Hornick JL; Doyle LA; Hirsch MS; Cramer DW; Drapkin R
Gynecol Oncol; 2014 Feb; 132(2):328-33. PubMed ID: 24342438
[TBL] [Abstract][Full Text] [Related]
19. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
[TBL] [Abstract][Full Text] [Related]
20. CD44 expression indicates favorable prognosis in epithelial ovarian cancer.
Sillanpää S; Anttila MA; Voutilainen K; Tammi RH; Tammi MI; Saarikoski SV; Kosma VM
Clin Cancer Res; 2003 Nov; 9(14):5318-24. PubMed ID: 14614016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
